1. Home
  2. NSPR vs CBAT Comparison

NSPR vs CBAT Comparison

Compare NSPR & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • CBAT
  • Stock Information
  • Founded
  • NSPR 2005
  • CBAT 1999
  • Country
  • NSPR United States
  • CBAT China
  • Employees
  • NSPR N/A
  • CBAT N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • CBAT Industrial Machinery/Components
  • Sector
  • NSPR Health Care
  • CBAT Miscellaneous
  • Exchange
  • NSPR Nasdaq
  • CBAT Nasdaq
  • Market Cap
  • NSPR 101.8M
  • CBAT 90.4M
  • IPO Year
  • NSPR N/A
  • CBAT N/A
  • Fundamental
  • Price
  • NSPR $2.41
  • CBAT $0.87
  • Analyst Decision
  • NSPR Strong Buy
  • CBAT
  • Analyst Count
  • NSPR 2
  • CBAT 0
  • Target Price
  • NSPR $4.50
  • CBAT N/A
  • AVG Volume (30 Days)
  • NSPR 78.7K
  • CBAT 193.7K
  • Earning Date
  • NSPR 11-11-2025
  • CBAT 11-11-2025
  • Dividend Yield
  • NSPR N/A
  • CBAT N/A
  • EPS Growth
  • NSPR N/A
  • CBAT N/A
  • EPS
  • NSPR N/A
  • CBAT N/A
  • Revenue
  • NSPR $7,066,000.00
  • CBAT $145,462,366.00
  • Revenue This Year
  • NSPR $7.48
  • CBAT N/A
  • Revenue Next Year
  • NSPR $104.39
  • CBAT $78.62
  • P/E Ratio
  • NSPR N/A
  • CBAT N/A
  • Revenue Growth
  • NSPR 7.60
  • CBAT N/A
  • 52 Week Low
  • NSPR $1.99
  • CBAT $0.57
  • 52 Week High
  • NSPR $3.80
  • CBAT $1.30
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 47.99
  • CBAT 34.31
  • Support Level
  • NSPR $2.37
  • CBAT $0.88
  • Resistance Level
  • NSPR $2.45
  • CBAT $0.92
  • Average True Range (ATR)
  • NSPR 0.07
  • CBAT 0.04
  • MACD
  • NSPR -0.00
  • CBAT -0.00
  • Stochastic Oscillator
  • NSPR 37.50
  • CBAT 24.44

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.

Share on Social Networks: